Fibrosis severity and graft loss in liver transplant recipients with hepatitis C are associated with older donor age. In their cohort study, which spanned three eras of donor age policies, Flemming et al. investigated the effect of restricting donor liver age for recipients with hepatitis C (to 30 years versus 48 years for recipients without hepatitis C). Donor age restriction had no obvious adverse effect on wait-list time or early post-transplantation survival.